Lanean...
In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes
BACKGROUND: Dalfampridine extended release tablets (dalfampridine-ER, known as prolonged-, modified, or sustained-release fampridine tablets in some countries) are approved for the improvement of walking in patients with multiple sclerosis (MS). Dalfampridine-ER is an extended release formulation of...
Gorde:
| Argitaratua izan da: | J Drug Assess |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Maney Publishing
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4937660/ https://ncbi.nlm.nih.gov/pubmed/27536444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21556660.2013.818544 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|